ArticlePharmacological reports : PR2024

AM1172 (a hydrolysis-resistant endocannabinoid analog that inhibits anandamide cellular uptake) reduces the viability of the various melanoma cells, but it exerts significant cytotoxic effects on healthy cells: an in vitro study based on isobolographic analysis.

Paweł Marzęda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.